Malignant lymphoma is a large group of diseases that can have dozens to many types depending on their specific pathological subtypes. The specific expected survival time varies between different types with different degrees of tumor malignancy and different treatment modalities. The survival time after suffering from malignant lymphoma is not the same, mainly related to the pathological type, treatment and individual patient’s condition, and should be analyzed on a problem-specific basis. Malignant lymphoma is a malignant tumor of the hematological system, and the survival time of patients varies with different pathological types. If the disease is found early, early and middle stage malignant lymphoma can be completely cured and survive for a long time through standard treatment, and some of them can effectively control the development of the disease and survive with the tumor for a long time, so the survival time of patients is not generalized. However, if the lymphoma is advanced with high malignancy, the effect of treatment is generally worse and the survival time of patients will be shortened, which still depends on the specific pathological typing and treatment. Therefore, patients with malignant lymphoma should go to the medical oncology department of regular hospitals in time, so that the professional doctors can formulate a rationalized treatment plan according to the individual situation of patients, which can help improve the quality of survival and prolong the survival time.